{"id":12176,"date":"2026-06-02T18:58:06","date_gmt":"2026-06-02T16:58:06","guid":{"rendered":"https:\/\/drwalterarboleda.com\/?p=12176"},"modified":"2026-06-02T18:58:06","modified_gmt":"2026-06-02T16:58:06","slug":"incidencia-mortalidad-y-supervivencia-en-cancer-de-mama-segun-subtipos-moleculares-en-manizales-2008-2019","status":"publish","type":"post","link":"https:\/\/drwalterarboleda.com\/index.php\/2026\/06\/02\/incidencia-mortalidad-y-supervivencia-en-cancer-de-mama-segun-subtipos-moleculares-en-manizales-2008-2019\/","title":{"rendered":"Incidencia, mortalidad y supervivencia en c\u00e1ncer de mama seg\u00fan subtipos moleculares en Manizales, 2008- 2019"},"content":{"rendered":"\n<p>La incidencia ajustada de los distintos subtipos de c\u00e1ncer de mama mostr\u00f3 un aumento significativo a lo largo del tiempo, especialmente en el subtipo Luminal A, Sin embargo, persiste una elevada incidencia de casos sin clasificar. Las pacientes con tumores Luminal A mostraron la mejor supervivencia, mientras que el subtipo triple negativo tuvo la peor evoluci\u00f3n, con dos veces el riesgo de muerte durante los primeros cinco a\u00f1os del diagn\u00f3stico, independientemente de otras variables. Estos resultados destacan la importancia de la clasificaci\u00f3n molecular, la detecci\u00f3n temprana y el acceso equitativo a terapias innovadoras para mejorar los desenlaces en Manizales y otras regiones del pa\u00eds.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/repositorio.ucaldas.edu.co\/entities\/publication\/231e7981-81fb-485c-85e1-a2ba26d98a56\" target=\"_blank\" rel=\"noreferrer noopener\">Ver Art\u00edculo<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La incidencia ajustada de los distintos subtipos de c\u00e1ncer de mama mostr\u00f3 un aumento significativo a lo largo del tiempo, especialmente en el subtipo Luminal A, Sin embargo, persiste una elevada incidencia de casos sin clasificar. Las pacientes con tumores Luminal A mostraron la mejor supervivencia, mientras que el subtipo triple negativo tuvo la peor &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/drwalterarboleda.com\/index.php\/2026\/06\/02\/incidencia-mortalidad-y-supervivencia-en-cancer-de-mama-segun-subtipos-moleculares-en-manizales-2008-2019\/\"> <span class=\"screen-reader-text\">Incidencia, mortalidad y supervivencia en c\u00e1ncer de mama seg\u00fan subtipos moleculares en Manizales, 2008- 2019<\/span> Leer m\u00e1s &raquo;<\/a><\/p>\n","protected":false},"author":2,"featured_media":12177,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/posts\/12176"}],"collection":[{"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/comments?post=12176"}],"version-history":[{"count":1,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/posts\/12176\/revisions"}],"predecessor-version":[{"id":12178,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/posts\/12176\/revisions\/12178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/media\/12177"}],"wp:attachment":[{"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/media?parent=12176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/categories?post=12176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drwalterarboleda.com\/index.php\/wp-json\/wp\/v2\/tags?post=12176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}